Correlation Between Catalyst Pharmaceuticals and Akebia Ther

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and Akebia Ther, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Akebia Ther.

Diversification Opportunities for Catalyst Pharmaceuticals and Akebia Ther

0.31

Correlation Coefficient

Catalyst Pharmaceuticals  Akebia Ther

Weak diversification

The 3 months correlation between Catalyst and Akebia is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Akebia Ther go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Akebia Ther

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.47 times more return on investment than Akebia Ther. However, Catalyst Pharmaceuticals is 2.11 times less risky than Akebia Ther. It trades about 0.09 of its potential returns per unit of risk. Akebia Ther is currently generating about 0.04 per unit of risk. If you would invest  2,107  in Catalyst Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  362.00  from holding Catalyst Pharmaceuticals or generate 17.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  Akebia Ther

Catalyst Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Akebia Ther

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Ther are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Akebia Ther sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Catalyst Pharmaceuticals and Akebia Ther

The main advantage of trading using opposite Catalyst Pharmaceuticals and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.

The idea behind Catalyst Pharmaceuticals and Akebia Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.